
Laura Lynne Stockton
Examiner (ID: 6934)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 2899, 1613, 1201, 1614, 1646, 1626 |
| Total Applications | 3246 |
| Issued Applications | 2197 |
| Pending Applications | 344 |
| Abandoned Applications | 753 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11568589
[patent_doc_number] => 20170107233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'NOVEL FUSED IMIDAZOBENZOTHIAZOLE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/128886
[patent_app_country] => US
[patent_app_date] => 2015-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21586
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15128886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/128886 | Fused imidazobenzothiazole compounds | Mar 23, 2015 | Issued |
Array
(
[id] => 10354843
[patent_doc_number] => 20150239849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'INHIBITORS OF BETA-SECRETASE'
[patent_app_type] => utility
[patent_app_number] => 14/662553
[patent_app_country] => US
[patent_app_date] => 2015-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22504
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14662553
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/662553 | INHIBITORS OF BETA-SECRETASE | Mar 18, 2015 | Abandoned |
Array
(
[id] => 11256773
[patent_doc_number] => 09481665
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-01
[patent_title] => 'Process for preparing PI3K inhibitor buparsilib'
[patent_app_type] => utility
[patent_app_number] => 14/656774
[patent_app_country] => US
[patent_app_date] => 2015-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3211
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14656774
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/656774 | Process for preparing PI3K inhibitor buparsilib | Mar 12, 2015 | Issued |
Array
(
[id] => 11492546
[patent_doc_number] => 20170066731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'SMALL MOLECULE FATTY ACID SYNTHASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/123218
[patent_app_country] => US
[patent_app_date] => 2015-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 28820
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15123218
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/123218 | Small molecule fatty acid synthase inhibitors | Mar 4, 2015 | Issued |
Array
(
[id] => 11336614
[patent_doc_number] => 20160362369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'METHOD FOR PRODUCING OPTICALLY ACTIVE AZETIDINONE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 15/120842
[patent_app_country] => US
[patent_app_date] => 2015-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3814
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15120842
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/120842 | METHOD FOR PRODUCING OPTICALLY ACTIVE AZETIDINONE COMPOUND | Feb 26, 2015 | Abandoned |
Array
(
[id] => 11568558
[patent_doc_number] => 20170107203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL'
[patent_app_type] => utility
[patent_app_number] => 15/121837
[patent_app_country] => US
[patent_app_date] => 2015-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18838
[patent_no_of_claims] => 123
[patent_no_of_ind_claims] => 58
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15121837
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/121837 | HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL | Feb 25, 2015 | Abandoned |
Array
(
[id] => 11596791
[patent_doc_number] => 09643942
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'Method for manufacturing 1,1-disubstituted hydrazine compound'
[patent_app_type] => utility
[patent_app_number] => 15/119191
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8797
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15119191
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/119191 | Method for manufacturing 1,1-disubstituted hydrazine compound | Feb 23, 2015 | Issued |
Array
(
[id] => 10354824
[patent_doc_number] => 20150239829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'SULFONAMIDE AND SULFINAMIDE PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/630248
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13103
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14630248
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/630248 | Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases | Feb 23, 2015 | Issued |
Array
(
[id] => 10306466
[patent_doc_number] => 20150191466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/628876
[patent_app_country] => US
[patent_app_date] => 2015-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59656
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14628876
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/628876 | Tropomyosin-related kinase (Trk) inhibitors | Feb 22, 2015 | Issued |
Array
(
[id] => 10642451
[patent_doc_number] => 09359305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-07
[patent_title] => 'Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/627595
[patent_app_country] => US
[patent_app_date] => 2015-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14714
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14627595
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/627595 | Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof | Feb 19, 2015 | Issued |
Array
(
[id] => 11914216
[patent_doc_number] => 09782388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'BIS-cyclic guanidine compound compositions, methods of use and treatment thereof'
[patent_app_type] => utility
[patent_app_number] => 15/120972
[patent_app_country] => US
[patent_app_date] => 2015-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 29543
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15120972
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/120972 | BIS-cyclic guanidine compound compositions, methods of use and treatment thereof | Feb 18, 2015 | Issued |
Array
(
[id] => 11743852
[patent_doc_number] => 20170197922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'BENZIMIDAZOL-2-AMINES AS MIDH1 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/118157
[patent_app_country] => US
[patent_app_date] => 2015-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76989
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15118157
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/118157 | Benzimidazol-2-amines as MIDH1 inhibitors | Feb 9, 2015 | Issued |
Array
(
[id] => 11743849
[patent_doc_number] => 20170197921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'BENZIMIDAZOL-2-AMINES AS MIDH1 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/118154
[patent_app_country] => US
[patent_app_date] => 2015-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77049
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15118154
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/118154 | Benzimidazol-2-amines as mIDH1 inhibitors | Feb 9, 2015 | Issued |
Array
(
[id] => 10593385
[patent_doc_number] => 09314456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-19
[patent_title] => 'Antibacterial compounds'
[patent_app_type] => utility
[patent_app_number] => 14/616006
[patent_app_country] => US
[patent_app_date] => 2015-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19225
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14616006
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/616006 | Antibacterial compounds | Feb 5, 2015 | Issued |
Array
(
[id] => 11381530
[patent_doc_number] => 20170007583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'Neurodegenerative Therapies'
[patent_app_type] => utility
[patent_app_number] => 15/116296
[patent_app_country] => US
[patent_app_date] => 2015-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12862
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15116296
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/116296 | Neurodegenerative therapies | Feb 3, 2015 | Issued |
Array
(
[id] => 10265875
[patent_doc_number] => 20150150872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'INHIBITORS OF BETA-SECRETASE'
[patent_app_type] => utility
[patent_app_number] => 14/613550
[patent_app_country] => US
[patent_app_date] => 2015-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18157
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14613550
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/613550 | Inhibitors of beta-secretase | Feb 3, 2015 | Issued |
Array
(
[id] => 11706135
[patent_doc_number] => 20170174635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'PROCESS FOR THE PREPARATION OF ENZALUTAMIDE'
[patent_app_type] => utility
[patent_app_number] => 15/116307
[patent_app_country] => US
[patent_app_date] => 2015-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1894
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15116307
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/116307 | PROCESS FOR THE PREPARATION OF ENZALUTAMIDE | Jan 29, 2015 | Abandoned |
Array
(
[id] => 10263549
[patent_doc_number] => 20150148546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'PHOTOSENSITIVE RESIN COMPOSITIONS, PROCESSES FOR PREPARING CURED FILMS, THE RESULTING CURED FILMS, ORGANIC EL DISPLAY DEVICES AND LIQUID CRYSTAL DISPLAY DEVICES'
[patent_app_type] => utility
[patent_app_number] => 14/607644
[patent_app_country] => US
[patent_app_date] => 2015-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 27390
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14607644
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/607644 | Photosensitive resin compositions, processes for preparing cured films, the resulting cured films, organic EL display devices and liquid crystal display devices | Jan 27, 2015 | Issued |
Array
(
[id] => 10256662
[patent_doc_number] => 20150141659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'SOLID FORMS OF AN ANTIVIRAL COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/600911
[patent_app_country] => US
[patent_app_date] => 2015-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 23197
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14600911
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/600911 | Solid forms of an antiviral compound | Jan 19, 2015 | Issued |
Array
(
[id] => 11721150
[patent_doc_number] => 09693992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'IRE-1α inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/594400
[patent_app_country] => US
[patent_app_date] => 2015-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 111324
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14594400
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/594400 | IRE-1α inhibitors | Jan 11, 2015 | Issued |